Table: Wakamoto Pharm -2018/19 parent results

Wakamoto Pharmaceutical

15/05/2019 07:00

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2019    Mar 31, 2018    Mar 31, 2020      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           10.74           10.90           11.30                  
               (-1.5 pct)      (+0.7 pct)      (+5.2 pct)                
  Operating   loss 391 mln     loss 73 mln      loss 1.80                
  Recurring   loss 409 mln     loss 80 mln      loss 1.80                
  Net         loss 181 mln       125 mln        loss 1.30                
                               (+32.9 pct)                               
  EPS         loss 5.22 yen     3.63 yen     loss 37.46 yen              
  Ann Div          NIL          3.00 yen           NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL          3.00 yen           NIL                   
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T